Tahoe Therapeutics
Agent45 out of 100, Above median. Agent Readiness. Open the scores section.Agent Readiness: 45/100. Above median. Measured by StartupHub.ai. Median 41.Trust54 out of 100, Below median. Data Trust. Open the scores section.Data Trust: 54/100. Below median. Measured by StartupHub.ai. Median 61.Developing novel therapies for neurological disorders.
About
Tahoe Therapeutics is a biotechnology company focused on developing innovative treatments for debilitating neurological diseases. Their research aims to address unmet medical needs in conditions such as Alzheimer's disease, Parkinson's disease, and ALS.
Listed competitors
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.
“Would a move to Biogen Regulatory Affairs from a top-10 pharma company make sense, given that my priorities are stability, career…” r/regulatoryaffairs
Also in this space
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Shares Biotech, MedTech
Biopharmaceutical company developing novel treatments for various diseases, including skin conditions and neurological disorders.
Shares Biotech, MedTech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Shares Biotech, MedTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Key facts
- Website
- tahoetherapeutics.com
- Headquarters
- San Mateo, United States
- Total funding
- $30M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Feb 2025 | Series A | $30M | Polaris Partners, Deerfield Management |
Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is Tahoe Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Tahoe Therapeutics is 54 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Tahoe Therapeutics raised?
Tahoe Therapeutics has raised a total of $30M in funding. The most recent round on record is Series A.
SEC filings, insider activity, nonprofit links and pay benchmarks for Tahoe Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
